Organization & Developments: DTRA

Parents

*Contractors & Awardees: DTRA
2010: University of Utah and Navigen Pharmaceuticals, Inc. Announce a New Government Contract to Advance Slit2N for the Treatment of Hemorrhagic Fever and Anthrax Exposure(2010)
2011: Could new drug cure nearly any viral infection? DRACOs (Double-stranded RNA Activated Caspase Oligomerizers) technology shows promise against common cold, influenza and other ailments (2011)
2019: DTRA_Military Algorithm Can Predict Illness 48 Hours Before Symptoms Show
2020: The US Military’s Latest Wearables Can Detect Illness Two Days Before You Get Sick
2022: Researchers Develop Chemical Agent-Resistant Coatings for Military Equipment
DTRA combines DoD resources, expertise, and capabilities to ensure the United States remains ready and able to address present and future WMD threats
DTRA Situational Awareness Functions
DTRA's mission is to safeguard the United States and its allies from chemical, biological, radiological, nuclear, and high-yield explosive WMDs
Georgetown University Project Argus:Research Partnerships
Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)
Proves capabilities to reduce, eliminate, and counter the threat and mitigate its effects.
Situational Awareness Deployable Teams
Strategic Command Center for Combating WMD
The Defense Threat Reduction Agency (DTRA) was founded in 1998 to integrate and focus the capabilities of the Department of Defense (DoD) that address the threat by weapons of mass destruction (WMD).